Mirviss Jeffrey B.
SEC CIK 1566094 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BSX | Boston Scientific | EVP, Pres, Periph Intervent | 25.8K | — | $18.19M | 71 | 2021-07-27 | 2025-02-24 |
Most active insiders at BSX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Mahoney Michael F | COB, Pres, CEO, Dir | $9.00M | $15.04M |
| 2 | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | — | $9.90M |
| 3 | Zane Ellen M | Dir | — | $2.57M |
| 4 | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | — | $1.76M |
| 5 | LUDWIG EDWARD J | Dir | $430.3K | — |
| 6 | Habiger David C | Dir | $407.9K | — |
| 7 | Morano Susan E | Dir | $100.4K | — |
| 8 | Pegus Cheryl | Dir | $100.0K | — |
| 9 | O'Connor Padraig Andrew | EVP, Gbl Ops | — | — |
| 10 | O'Sullivan Miriam | SVP, Chief HR Off | — | — |
Mirviss Jeffrey B. made no open-market trades at BSX in the last 12 months.
Transactions 71
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-25 | 2025-02-24+ | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $104.16 | -7,363 | 25.8K | -22% | -$766.9K |
| 2025-02-19 | 2025-02-19 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $105.35 | -1,510 | 33.1K | -4% | -$159.1K | |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $106.11 | -4,142 | 34.6K | -11% | -$439.5K |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +9,080 | 32.5K | +39% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +2,115 | 30.6K | +7% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $105.77 | -868 | 29.7K | -3% | -$91.8K |
| 2025-02-13 | 2025-02-12 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $105.06 | -13.0K | 28.5K | -31% | -$1.37M | |
| 2025-02-13 | 2025-02-11 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $105.98 | -10.7K | 41.5K | -21% | -$1.14M | |
| 2025-02-13 | 2025-02-11 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | A - Grant | $0.00 | +23.8K | 52.2K | +84% | $0 | |
| D | 2025-01-03 | 2025-01-01 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +10.4K | 38.9K | +37% | $0 |
| D | 2025-01-03 | 2025-01-01 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $89.32 | -3,278 | 35.6K | -8% | -$292.8K |
| D | 2025-01-03 | 2025-01-03 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale+OE | $89.86 | -7,152 | 28.5K | -20% | -$642.7K |
| D | 2024-05-30 | 2024-05-29 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale+OE | $75.10 | -63.8K | 28.0K | -69% | -$4.79M |
| D | 2024-05-30 | 2024-05-29 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $17.26 | +33.7K | 91.8K | +58% | +$582.1K |
| 2024-03-19 | 2024-03-18 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $66.45 | -14.5K | 58.1K | -20% | -$963.9K | |
| 2024-02-22 | 2024-02-21 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $66.35 | -4,960 | 72.6K | -6% | -$329.1K | |
| DM | 2024-02-20 | 2024-02-16+ | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $65.82 | -4,160 | 76.0K | -5% | -$273.8K |
| DM | 2024-02-20 | 2024-02-16+ | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +9,120 | 75.6K | +14% | $0 |
| D | 2024-02-16 | 2024-02-14 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $65.95 | -1,266 | 72.6K | -2% | -$83.5K |
| D | 2024-02-16 | 2024-02-14 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +2,776 | 73.9K | +4% | $0 |
| 2024-02-08 | 2024-02-06 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | A - Grant | $0.00 | +26.7K | 83.3K | +47% | $0 | |
| 2024-02-08 | 2024-02-06 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $0.00 | -12.2K | 71.1K | -15% | $0 | |
| D | 2024-01-10 | 2024-01-09 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale+OE | $59.25 | -15.2K | 56.6K | -21% | -$898.9K |
| D | 2024-01-10 | 2024-01-09 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $16.31 | +15.2K | 71.8K | +27% | +$247.5K |
| D | 2024-01-05 | 2024-01-04 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale+OE | $58.40 | -15.0K | 56.6K | -21% | -$876.0K |
| D | 2024-01-05 | 2024-01-04 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $16.31 | +15.0K | 71.6K | +27% | +$244.6K |
| 2024-01-04 | 2024-01-03 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $57.82 | -11.9K | 56.6K | -17% | -$689.9K | |
| D | 2024-01-02 | 2024-01-01 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $57.81 | -5,508 | 68.5K | -7% | -$318.4K |
| D | 2024-01-02 | 2024-01-01 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +17.4K | 74.0K | +31% | $0 |
| 2023-12-07 | 2023-12-06 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $55.03 | -353 | 56.6K | -0.6% | -$19.4K | |
| D | 2023-12-04 | 2023-12-03 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +649 | 57.2K | +1% | $0 |
| D | 2023-12-04 | 2023-12-03 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $56.14 | -296 | 56.9K | -0.5% | -$16.6K |
| 2023-11-09 | 2023-11-08 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | G - Gift | $0.00 | -4,000 | 56.6K | -7% | $0 | |
| M | 2023-08-30 | 2023-08-28+ | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $53.48 | -18.6K | 65.2K | -22% | -$996.2K |
| 2023-04-06 | 2023-04-05 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $50.40 | -4,903 | 78.7K | -6% | -$247.1K | |
| 2023-03-31 | 2023-03-30 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $49.60 | -4,903 | 83.6K | -6% | -$243.2K | |
| DM | 2023-02-22 | 2023-02-21+ | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale+OE | $46.19 | -5,653 | 91.8K | -6% | -$261.1K |
| D | 2023-02-22 | 2023-02-21 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +2,804 | 95.4K | +3% | $0 |
| D | 2023-02-22 | 2023-02-21 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $46.23 | -1,279 | 94.1K | -1% | -$59.1K |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $46.52 | -2,931 | 91.9K | -3% | -$136.4K |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +9,120 | 92.9K | +11% | $0 |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale+OE | $46.53 | -3,470 | 90.5K | -4% | -$161.5K |
| D | 2023-02-16 | 2023-02-15 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $47.29 | -622 | 89.9K | -0.7% | -$29.4K |
| D | 2023-02-16 | 2023-02-15 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +2,031 | 90.5K | +2% | $0 |
| 2023-01-04 | 2023-01-04 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $46.38 | -6,751 | 88.5K | -7% | -$313.1K | |
| D | 2023-01-03 | 2023-01-01 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +9,981 | 98.5K | +11% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $46.27 | -3,230 | 95.2K | -3% | -$149.5K |
| 2022-12-13 | 2022-12-12 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $46.75 | -11.1K | 88.5K | -11% | -$518.0K | |
| D | 2022-12-12 | 2022-12-09 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale+OE | $46.15 | -41.0K | 99.6K | -29% | -$1.89M |
| D | 2022-12-12 | 2022-12-09 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $13.08 | +29.6K | 140.6K | +27% | +$387.2K |
| DM | 2022-12-05 | 2022-05-16+ | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | G - Gift | $0.00 | -256 | 110.6K | -0.2% | $0 |
| D | 2022-12-05 | 2022-12-03 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $46.60 | -296 | 111.0K | -0.3% | -$13.8K |
| D | 2022-12-05 | 2022-12-03 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +649 | 111.3K | +0.6% | $0 |
| 2022-04-21 | 2022-04-20 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $46.50 | -9,645 | 110.3K | -8% | -$448.5K | |
| 2022-04-20 | 2022-04-19 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $45.50 | -11.0K | 120.0K | -8% | -$500.0K | |
| 2022-03-23 | 2022-03-22 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $44.50 | -11.2K | 130.9K | -8% | -$500.0K | |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +2,037 | 142.8K | +1% | $0 |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $44.17 | -624 | 142.2K | -0.4% | -$27.6K |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $42.55 | -859 | 140.8K | -0.6% | -$36.6K |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +2,804 | 141.6K | +2% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +6,149 | 137.9K | +5% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $42.70 | -1,882 | 136.9K | -1% | -$80.4K |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $44.01 | -622 | 134.6K | -0.5% | -$27.4K |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +2,030 | 135.2K | +2% | $0 |
| 2022-01-05 | 2022-01-04 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $43.54 | -6,840 | 133.2K | -5% | -$297.8K | |
| D | 2022-01-03 | 2022-01-01 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +10.1K | 143.3K | +8% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $42.48 | -3,265 | 140.0K | -2% | -$138.7K |
| DM | 2021-12-06 | 2021-08-30+ | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | G - Gift | $0.00 | -318 | 132.9K | -0.2% | $0 |
| D | 2021-12-06 | 2021-12-03 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $39.46 | -296 | 133.2K | -0.2% | -$11.7K |
| D | 2021-12-06 | 2021-12-03 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | M - OptEx | $0.00 | +649 | 133.4K | +0.5% | $0 |
| 2021-07-27 | 2021-07-27 | BSX | Boston Scientific | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $45.22 | -6,748 | 133.1K | -5% | -$305.1K |
Purchase Sale Sale after option exercise All abbreviations